What baseline laboratory tests are recommended for a patient with psoriasis prior to initiating systemic or biologic therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Baseline Laboratory Testing for Psoriasis Prior to Systemic/Biologic Therapy

All patients initiating systemic or biologic therapy for psoriasis require baseline tuberculosis screening, complete blood count (CBC), comprehensive metabolic panel (CMP) with liver and kidney function tests, and hepatitis B/C screening. 1

Essential Baseline Tests

Tuberculosis Screening (Strongest Evidence)

  • Interferon-gamma release assay (IGRA) is preferred over tuberculin skin testing for TB screening before starting biologics 2
  • This is the only screening test with Grade B evidence supporting its routine use 2
  • Mandatory before initiating any TNF-alpha inhibitor or IL-12/23 inhibitor 3

Hepatitis Screening

  • Test for hepatitis B surface antigen, surface antibody, and core antibody at baseline 3
  • Test for hepatitis C antibody 3
  • Patients with positive hepatitis B core antibody (resolved infection) require monitoring for reactivation but don't need specialist follow-up initially 3
  • Active hepatitis B carriers can receive biologics but need concomitant antiviral therapy, specialist consultation, and monitoring of liver function tests plus viral load (Grade C evidence) 3, 2

Complete Blood Count and Chemistry Panel

  • CBC with differential and platelet count 1, 4
  • Comprehensive metabolic panel including:
    • Liver function tests (AST, ALT, alkaline phosphatase, bilirubin) 1, 4
    • Kidney function (creatinine, BUN) 1
    • Electrolytes (particularly potassium if considering cyclosporine) 1

HIV Testing

  • Consider in patients with risk factors or severe/atypical psoriasis presentations 3
  • Patients with HIV can receive biologics if CD4 count is normalized and viral load undetectable on HAART 3

Medication-Specific Monitoring Requirements

For Methotrexate

Baseline: CBC, CMP with liver function tests, hepatitis B/C screening, pregnancy test in women of childbearing age 1

  • Assess hepatic fibrosis risk factors: obesity, diabetes, history of alcohol use (>1 drink/day for women, >2 drinks/day for men), prior liver disease 1
  • If risk factors present: consider GI/hepatology referral or vibration-controlled transient elastography before starting 1
  • Contraindicated in pregnancy - ensure effective contraception 1

For Cyclosporine

Baseline: CBC, CMP, lipid panel, uric acid, magnesium, blood pressure 1

  • Establish baseline kidney function as nephrotoxicity is dose-limiting 1
  • Contraindicated if: baseline renal insufficiency, uncontrolled hypertension, prior PUVA treatment, active malignancy (except non-melanoma skin cancer) 1

For Biologics (TNF-alpha, IL-17, IL-23, IL-12/23 inhibitors)

Baseline: TB screening (IGRA preferred), CBC, CMP, hepatitis B/C screening 3, 2, 4

  • Pregnancy test in women of childbearing age
  • No routine monitoring of antinuclear antibodies recommended despite variable practice patterns 4

Important Caveats

Elevated Liver Function Tests Are NOT a Contraindication

Recent real-world evidence demonstrates that elevated baseline LFTs should not prevent initiation of modern biologics (secukinumab, ixekizumab, adalimumab, apremilast) 5. In fact, LFTs often improve during treatment, and drug survival/efficacy are equivalent regardless of baseline LFT status 5. This challenges the common pitfall of withholding effective therapy due to mild LFT elevations.

Evidence Limitations

Most screening recommendations beyond TB testing lack strong evidence 2, 6. The Grade B recommendation for TB screening stands alone; most other tests have Grade C evidence or are based on expert opinion and package insert requirements 2. However, the absence of evidence for harm combined with low test burden justifies comprehensive baseline screening in clinical practice.

Pregnancy Considerations

  • Methotrexate requires 3-month washout before conception 1
  • Acitretin requires extended washout (not detailed in provided evidence but known to be prolonged)
  • Most biologics have limited pregnancy data; discuss risks with patients of childbearing potential

Practical Algorithm

  1. All patients: TB screening (IGRA), CBC, CMP, hepatitis B/C panel
  2. Add if methotrexate planned: Hepatic fibrosis risk assessment, pregnancy test
  3. Add if cyclosporine planned: Lipid panel, uric acid, magnesium, blood pressure
  4. Add if risk factors present: HIV testing, pregnancy test (all women of childbearing age)
  5. Do NOT routinely check: ANA, cyclosporine drug levels, or biologic drug levels at baseline 4

This approach balances evidence-based practice with real-world safety considerations, recognizing that baseline screening protects patients while avoiding unnecessary barriers to effective therapy.

References

Related Questions

What biologic agents are appropriate first‑line treatments for an adult with moderate‑to‑severe plaque psoriasis who has failed or cannot tolerate topical therapy, and what screening and monitoring considerations are required?
What are the brand names of topical creams (and related formulations) used to treat psoriasis, including their generic equivalents?
What is the most likely cause of the red‑brown macules on the palms and soles in a 40‑year‑old man with known knee psoriasis?
What are the indications, recommended biologic agents, dosing regimens, baseline screening requirements, and monitoring guidelines for patients with moderate-to-severe inflammatory or autoimmune diseases who have not achieved adequate control with conventional non‑biologic therapies?
What is the recommended perioperative management of systemic psoriasis therapies for a patient undergoing coronary artery bypass grafting (CABG)?
Is the Medrol dose pack (methylprednisolone) gluten‑free?
What are the recommended dosing guidelines for urea cream (including concentration and frequency) for various dermatologic conditions such as xerosis, ichthyosis, psoriasis, and thickened plantar skin?
Is the inactivated anti‑rabies vaccine safe for a lactating mother who is breastfeeding a 10‑month‑old infant?
Do maintenance allergy immunotherapy shots begin with a red‑vial preparation?
How long should a patient remain in a sling after a Grade III acromioclavicular (AC) separation?
What is the safest and most effective anesthesia for routine outpatient colonoscopy in an adult (ASA I‑III)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.